Altered thyroid axis function in lewis rats with genetically defective hypothalamic CRH/VP neurosecretory cells

References

• Sternberg E M, Hill J M, Chrousos G P, Kamilaris T, Listwak S J, Gold P W, Wilder R L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U.S.A 1989; 86: 2374–2378
   PubMed Web of Science ®Google Scholar
• Sternberg E M, Young W S, III, Bernardini R, Calogero A E, Chrousos G P, Gold P W, Wilder R L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U.S.A 1989; 86: 4771–4775
   PubMed Web of Science ®Google Scholar
• MacPhee I A, Antoni F A, Mason D W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989; 169: 431–445
   PubMed Web of Science ®Google Scholar
• Griffin A C, Whitacre C C. Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease. J Neuroimmunol 1991; 35: 53–64
   PubMed Web of Science ®Google Scholar
• Villas P A, Dronsfield M J, Blankenhorn E P. Experimental allergic encephalomyelitis and corticosterone. Clin Immunol Immunopathol 1991; 61: 29–40
   Google Scholar
• Calogero A E, Sternberg E M, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder R L, Gold P W, Chrousos G P. Neurotransmitter-induced hypothalamo-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 1992; 55: 600–608
   PubMedGoogle Scholar
• Perretti M, Duncan G S, Flower R J, Peers S H. Serum corticosterone interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strains. Br J Pharmacol 1993; 110: 868–874
   Google Scholar
• Whitnall M H, Anderson K A, Lane C A, Mougey E H, Neta R, Perlstein R S. Decreased vasopressin content in CRH neurosecretory system of Lewis rats. NeuroReport 1994; 5: 1635–1637
   Google Scholar
• Patchev V K, Mastorakos G, Brady L S, Redwine J, Wilder R L, Chrousos G P. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 1993; 58: 106–110
   Google Scholar
• Lumpkin M D, Samson W K, McCann S M. Arginine vasopressin as a thyrotropin-releasing hormone. Science (Washington DC) 1987; 235: 1070–1073
   Google Scholar
• Childs G V, Westlund K N, Unabia G. Characterization of anterior pituitary target cells for arginine vasopressin: including cells that store adrenocorticotropin, thyrotropin-beta, and both hormones. Endocrinology 1989; 125: 554–559
   PubMed Web of Science ®Google Scholar
• Bernton E W, Beach J E, Holaday J W, Smallridge R C, Fein H G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science (Washington DC) 1987; 238: 519–521
   PubMed Web of Science ®Google Scholar
• Bernardini R, Iurato M P, Chiarenza A, Lempereur L, Calogero A E, Sternberg E M. Adenylate-cyclase-dependent pituitary adrenocorticotropin secretion is defective in the inflammatory-disease-susceptible Lewis rat. Neuroendocrinology 1996; 63: 468–474
   Google Scholar
• Rivest S, Rivier C. Stress and interleukin-1ß-induced activation of c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: comparison between Sprague-Dawley, Fisher-344 and Lewis rats. J Neuroendocrinol 1994; 6: 101–117
   Google Scholar
• Fujimoto S, Hedge G A. Altered pituitary-thyroid function in the Brattleboro rat with diabetes insipidus. Endocrinology 1982; 110: 1628–1633
   Google Scholar
• Nicoloff J T, Fisher D, Appleman M D. The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest 1970; 49: 1922–1929
   PubMed Web of Science ®Google Scholar
• Gharib H, Hodgson S F, Gastineau C F, Scholz D A, Smith L A. Reversible hypothyroidism in Addison's disease. Lancet 1972; 2: 734–736
   PubMed Web of Science ®Google Scholar
• Re R N, Kourides L A, Ridgeway E C, Weintraub B D, Maloof F. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab 1976; 43: 338–346
   PubMed Web of Science ®Google Scholar
• Duick D S, Wahner H W. Thyroid axis in patients with Cushing's syndrome. Arch Intern Med 1979; 139: 767–772
   Google Scholar
• Topliss D J, White E L, Stockigt J R. Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab 1980; 50: 52–56
   PubMedGoogle Scholar
• Visser T J, Lambert S W.J. Regulation of TSH secretion and thyroid function in Cushing's disease. Acta Endocrinol 1981; 96: 480–483
   Google Scholar
• Barnett A H, Donald R A, Espiner E A. High concentrations of thyroid-stimulating hormone in untreated glucocorticoid deficiency: indication of primary hypothyroidism?. Br Med J 1982; 285: 172–173
   Google Scholar
• Gonzalez J J, Werk E E, Jr. Abnormal thyrotropin and prolactin levels in untreated corticotropin deficiency. Arch Intern Med 1985; 145: 356–357
   Google Scholar
• Redei E, Hilderbrand H, Aird F. Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178–199). Endocrinology 1995; 136: 3557–3563
   Google Scholar
• Cizza G, Brady L S, Pacak K, Blackman M R, Gold P W, Chrousos G P. Stress-induced inhibition of the hypothalamic-pituitary-thyroid axis is attenuated in the aged Fischer 344/N male rat. Neuroendocrinology 1995; 62: 506–513
   PubMed Web of Science ®Google Scholar
• Hisano S, Fukui Y, Chikamori-Aoyama M, Aizawa T, Shibasaki T. Reciprocal synaptic relations between CRF-immunoreactive and TRH-immunoreactive neurons in the paraventricular nucleus of the hypothalamus. Brain Res 1993; 620: 343–346
   Google Scholar
• Wilber J F, Utiger R D. The effect of glucocorticoids on thyrotropin secretion. J Clin Invest 1969; 48: 2096–2103
   PubMed Web of Science ®Google Scholar
• Brown M R, Hedge G A. Effects of glucocorticoids on TRH and TSH secretion: dose and time considerations. Am J Physiol 1974; 227: 289–294
   Google Scholar
• Ahlquist JA O, Franklyn J A, Ramsden D B, Sheppard M C. The influence of dexamethasone on serum thyrotrophin and thyrotrophin synthesis in the rat. Mol Cell Endocrinol 1989; 64: 55–61
   PubMed Web of Science ®Google Scholar
• Brabant A, Brabant G, Schuermeyer T, Ranft U, Schmidt F W, Hesch R D, Muhlen A V.Z. The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol 1989; 121: 95–100
   Google Scholar
• Kakucska I, Qi Y, Lechan R M. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone. Endocrinology 1995; 136: 2795–2802
   PubMed Web of Science ®Google Scholar
• Larsen P R, Ingbar S H. The thyroid gland. Williams Textbook of Endocrinology, J D Wilson, D W Foster. W.B. Saunders, Philadelphia 1992; pp. 357–487
   Google Scholar
• Nicholson W E, Orth D N. Preprothyrotropin-releasing hormone-(178–199) does not inhibit corticotropin release. Endocrinology 1996; 137: 2171–2174
   Google Scholar
• Rettori V, Jurcovicova J, McCann S M. Central action of interleukin-1 in altering the release of TSH, growth hormone, and prolactin in the male rat. J Neurosci Res 1987; 18: 179–183
   PubMed Web of Science ®Google Scholar
• Dubois J-M, Dayer J-M, Siegrist-Kaiser C A, Burger A G. Human recombinant interleukin-1ß decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 1988; 123: 2175–2181
   Google Scholar
• Pang X-P, Hershman J M, Mirell C J, Pekary A E. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-α (cachectin). Endocrinology 1989; 125: 76–84
   Google Scholar
• Van der PT, Romijn J A, Wiersinga W M, Sauerwein H P. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71: 1567–1572
   PubMed Web of Science ®Google Scholar
• Hermus AR MM, Sweep CG J, van der Meer MJ M, Ross H A, Smals AG H, Benrad T J, Kloppenborg P W.C. Continuous infusion of interleukin-1β induces a nonthyroidal illness syndrome in the rat. Endocrinology 1992; 131: 2139–2146
   PubMed Web of Science ®Google Scholar
• Kakucska I, Romero L I, Clark B D, Rondeel JM M, Qi Y, Alex S, Emerson C H, Lechan R M. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology 1994; 59: 129–137
   PubMed Web of Science ®Google Scholar